Five years after Medtronic's billion-dollar purchase of HeartWare International, the company discontinued the device at the center of acquisition — a miniaturized, implantable heart pump — with no ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. A congressional oversight subcommittee is investigating the ...

SALT LAKE CITY- Surgeons at University of Utah Hospital have performed the hospital’s first implant of a new generation left ventricular assist device (LVAD) using the HeartWare HVAD. The tiny, ...

Medtronic’s HeartWare Ventricular Assist Device (HVAD) may be off the market, but it’s still very much on the company’s mind. The devicemaker discontinued new sales and implants of its HeartWare ...

The FDA alerted health care providers to another potential issue with Medtronic's HeartWare Ventricular Assist Device this week, saying a welding defect may cause it to malfunction. Medtronic notified ...

HeartWare International Inc. files a pre-market approval application with the Food & Drug Administration for a ventricular assist device designed as a bridge-to-transplant system. HeartWare ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9cqxw2/global) has announced the addition of the "Global Ventricular Assist ...

HeartWare International (HTWR), a leading manufacturer of heart devices, recently submitted a Pre-Market Approval (“PMA”) application to the U.S. Food and Drug Administration (“FDA”), for its ...

San Diego,CA-Patients implanted for bridge therapy with the continuous-flow ventricular assist device (VAD) from HeartWare International fared about as well in a 110-patient extension of the ...

SILVER SPRING, Maryland — As expected, the FDA has approved the HeartWare Ventricular Assist System (HeartWare, Framingham, MA) as bridge therapy for patients awaiting heart transplantation [1]. In ...